DSM - Repurchase of Shares (10 - 14 September 2018)

HEERLEN, Netherlands, September 18, 2018 /PRNewswire/ --

Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, has repurchased 94,032 of its own shares in the period from 10 September 2018 up to and including 14 September 2018 at an average price of €88.38. This is in accordance with the repurchase, covering commitments under share based compensation plans and for stock dividends, announced on 13 August 2018. The consideration of this repurchase was €8.3 million. 

     (Logo: https://mma.prnewswire.com/media/657851/DSM_Logo.jpg )

The total number of shares repurchased under this program to date is 699,443 shares for a total consideration of €62.5 million.

For more detailed information see 'Daily transaction details 1.1m Share Repurchase Program announced 13 Aug 2018'.

DSM - Bright Science. Brighter Living.™ 

Royal DSM is a purpose-led global science-based company in Nutrition, Health and Sustainable Living. DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative business solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company is listed on Euronext Amsterdam. More information can be found at http://www.dsm.com.

Or find us on:

Facebook
Twitter
LinkedIn
YouTube

Forward-looking statements

This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

For more information:
DSM Media Relations
Lieke de Jong
tel. +31(0)45-578-2420        
e-mail media.contacts@dsm.com

DSM Investor Relations
Dave Huizing
tel. +31(0)45-578-2864
e-mail investor.relations@dsm.com

    PRN NLD